Skip to Content

93 7441 (Divalproex sodium delayed-release 500 mg)

Pill with imprint 93 7441 is Orange, Elliptical / Oval and has been identified as Divalproex sodium delayed-release 500 mg. It is supplied by Teva Pharmaceuticals USA.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 93 7441

Divalproex sodium delayed-release

93 7441
500 mg
19.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
hypromellose 2910 (6 mPa.s)
hypromellose phthalate (31% phthalate, 40 cst)
ferrosoferric oxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 3350
polyvinyl alcohol
povidone k30
corn starch
propylene glycol
silicon dioxide
magnesium silicate
titanium dioxide
triethyl citrate
ferric oxide red
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.